Results For "anti-infective-portfolio"

No record found.

Upcoming E-conference

June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?

July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

Lupin Manufacturing Solutions appoints Eduardo Jule as Chief Commercial Officer

Smile Foundation delivers 20 lakh healthcare treatments in FY26

Manipal Hospital Dhakuria raises ovarian cancer awareness

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews

Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences

Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences

Dr. Ramesh Hariharan Chief Executive Officer, Strand Life Sciences

India’s medical devices sector is poised for a pharma-like transformation: Pranav Sharma, SBU Head - Advanced Surgery, Healthium MedTech

India’s medical devices sector is poised for a pharma-like transformation: Pranav Sharma, SBU Head - Advanced Surgery, Healthium MedTech

Pranav Sharma Strategic Business Unit Head - Advance Surgery, Healthium MedTech

Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India

Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India

Packaging